New Laser Aims to Zap Cellulite at the Source
Rating
New Laser Aims to Zap Cellulite at the Source
Our Review Summary
For a column entitled “Aches & Claims,” this entry caused us many aches because it didn’t adequately evaluate claims, such as:
- “The results are nothing short of remarkable.”
- “Cellulite reduction was good to excellent as graded by physicians.”
- “Substantial improvement two years after surgery.”
Why This Matters
It’s ironic that one week after the big brouhaha over the Supreme Court decision on the Affordable Care Act, a story like this about a cosmetic treatment that costs a minimum of $5,000 – 7,500 never mentioned insurance coverage.
There are many reasons Americans spend a far greater percentage of the GDP on health care than anyone else on the face of the Earth. And stories like this capture just one little slice.
Cosmetic dermatology is one of the few domains in medicine where the “free market” reigns. Although devices such as the laser highlighted in this story are approved by the FDA, the approval process does not guarantee the results. That’s why it is so important to provide readers with as much information about new devices and new approaches as possible.
Criteria
Satisfactory
Costs were discussed. But the story didn’t discuss insurance coverage. One online reader did, though, writing:
“Interesting how while plastic surgery isn’t covered by health insurance, the follow-up care and complications often are. The side effects of this procedure sound horrific, and we all get to pay for it.”
Not Satisfactory
Deep in the story, a company-funded study of 10 (!) women was discussed – resulting in “skin that was 25% thicker after a year.” What does that mean? What is the true benefit of that? The story says doctors graded cellulite reduction as “good to excellent.” In all 10 women? Was this a subjective judgment?
Then the story cites unpublished data from a company-financed trial trial. Might as well have been a news release. Hardly a good source of evidence to cite at this point.
By the end, there really was no good quantification of benefit.
Interestingly, the story provides no information about what the subjects thought about the results.
Not Satisfactory
Potential harms were mentioned:
Cellulaze leaves tiny scars—about two millimeters long—which fade with time, surgeons say. Typically, compression garments are recommended for at least two or three weeks to prevent fluid buildup. And there will be bruises, so patients typically need to wait three to six weeks before venturing out in a bathing suit, surgeons say.
The procedure can cause a buildup of fluid in the area that has been treated, which can last for months and needs to be drained regularly by a doctor.
In a written statement, Cynosure says “a few” patients in early trials had the buildups, called seromas, adding that they need to be drained to prevent infections and other complications. The company says it has since lowered the recommended laser dosage and it isn’t aware of any seromas since the device hit the U.S. market.
But none of these harms was quantified, so the scope of the potential harm wasn’t clear. What does it actually mean when the story uses vague terms such as “typically”…”can cause”…”a few patients” ?
Not Satisfactory
One independent perspective came from a dermatologist who said “”we need more clinical experience before we can make any definitive statements as to the efficacy of the device.”
But the rest of the story was cheerleading in its failure to explain or evaluate the evidence:
- failing to point how laughably small is a company-funded study of 10 women
- failing to point out the folly of citing data from a company-funded trial that is not published
Not Satisfactory
Pretty egregious disease-mongering – both in what the story said and it what it didn’t say.
What it said:
Bathing-suit season is here and with it, anxiety over cellulite. A new laser device that burrows under the skin is getting praise from some doctors who say it gives more dramatic and longer-lasting results than previous treatments, but others caution that more research is needed.
Cellulite is a dimpled, uneven appearance of skin caused by fat underneath. It affects some 85% of women and about 5% of men.
What it didn’t say:
- It didn’t have one word about why/whether cellulite needs to be treated.
- It didn’t cite the source of the data for how many people are affected. And of those supposed 85% of women and 5% of men, are they ALL considered candidates for treatment? And if so, by whom? With what vested interest?
Finally, the story described the “battle” with cellulitis, which conjures up images of fat cells being taken on by light sword-armed dermatologists to save humanity from the scourge of dimpled thighs. Battle? Really?
Satisfactory
There were two apparently independent sources quoted.
Not Satisfactory
In a practice that is far too common in such stories, this one mentioned alternatives but waved them off as ineffective without citing any data.
Until recently, the main treatments to battle cellulite have been external treatments such as creams and radio-frequency and massage devices. The creams are largely ineffective and the devices have a modest effect that typically lasts about six months, doctors say.
Meantime, this entire story was based on two company-funded studies – one tiny and one unpublished!!!
Satisfactory
The story stated that the laser approach “hit the US market in February.”
Satisfactory
The story at least mentioned one other “new laser treatment for cellulite and body contouring.” (Although the only data cited on that approach also came from a tiny, unpublished study.)
Satisfactory
Because two apparently independent experts were quoted, it does not appear that the story relied solely on a news release.
Total Score: 5 of 10 Satisfactory
Comments (1)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Clarence Keith
September 28, 2016 at 11:51 pmNice!!
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like